510(k) Report

510(k) · Cleared

Cleared

Bipore Balloon Dilatation Catheter

K973563510(k) TraditionalCleared Apr 1, 1998194-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bipore, Inc. · LIT Catheter, Angioplasty, Peripheral, Transluminal

Cleared on Apr 1, 1998 as substantially equivalent to K961980 (Bipore, Inc., 1996) after a 194-day review. Its family tree reaches back 2 generations to 1990.

Decided
Apr 1, 1998
Review
194 days
Class
Class II
Product code
LIT
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K897106 (1990). 3 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1992: 1 other ancestorK897106 · Medi-Tech Dilatation Catheters Ultra Thin II · Boston Scientific Corp · 1990K961980 · Bipore Balloon Dilatation Catheter · Bipore, Inc. · 1996199019921994199619982000
Other ancestors, by generation 2 generations back: 1 other ancestor K961980 · Bipore Balloon Dilatation Catheter · Bipore, Inc. · 1996K897106 · Medi-Tech Dilatation Catheters Ultra Thin II · Boston Scientific Corp · 19900
  1. Root · 2 generations backK897106 Medi-Tech Dilatation Catheters Ultra Thin IIBoston Scientific Corp · 1990
  2. 1 generation backK961980 Bipore Balloon Dilatation CatheterBipore, Inc. · 1996
  3. This deviceK973563 Bipore Balloon Dilatation CatheterBipore, Inc. · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K897106Medi-Tech Dilatation Catheters Ultra Thin IIBoston Scientific Corp1990—
−1K961980Bipore Balloon Dilatation CatheterBipore, Inc.1996—
0 (this device)K973563Bipore Balloon Dilatation CatheterBipore, Inc.1998—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199210
FIG. 1 — Lineage of K973563, 1990–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LIT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LIT device

  1. #1 K241040 Amethyst HP PTA OTW 0.035 Catheterscore 13.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K961980Bipore Balloon Dilatation Catheter
Summary page 1
…Parkway Northvale, NJ 07647 Tel (201)767-1993 Fax (201) 767-0435 Balloon Dilatation Catheter Class I, Performance Standards Bipore Balloon Dilatation Catheter 510(k) K961980 The Bipore Balloon Dilatation Catheter is a double lumen balloon catheter for percutancous transluminal angioplasty in periphera…
Bipore, Inc.1996—

Also cleared against K961980: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 8 years and passes through 2 companies; a new generation was cleared every 5.9 years on median.
  • None of the 3 ancestors has a recall.
  • 1 other device also cites its predicate K961980.

How does its category compare?

All LIT devices

LIT Catheter, Angioplasty, Peripheral, Transluminal: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LIT

3in 2025

2007: 62008: 82009: 72010: 132011: 102012: 192013: 142014: 122015: 192016: 112017: 92018: 62019: 42020: 92021: 42022: 82023: 62024: 62025: 32026 (partial year): 4
2007high 19 (2012) · low 3 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LIT

90in 2025

2007: 64 days median2008: 53 days median2009: 29 days median2010: 78 days median2011: 82 days median2012: 29 days median2013: 79 days median2014: 90 days median2015: 112 days median2016: 116 days median2017: 57 days median2018: 118 days median2019: 40 days median2020: 125 days median2021: 61 days median2022: 122 days median2023: 167 days median2024: 43 days median2025: 90 days median2026 (partial year): 205 days median
2007high 205 (2026) · low 29 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LIT

1in 2025

2009: 22010: 12013: 2, 2 Class I2014: 32016: 12018: 22019: 32021: 12024: 22025: 1
2007high 3 (2014) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · LIT

2,073in 2025

2007: 5772008: 5132009: 6232010: 8092011: 8572012: 1,2772013: 1,2422014: 1,1782015: 1,2792016: 1,5292017: 2,0812018: 2,1882019: 2,4052020: 2,4432021: 2,4922022: 2,1552023: 1,8072024: 1,9132025: 2,073
2007high 2,492 (2021) · low 513 (2008)2025

MAUDE reports naming product code LIT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076640577
20088530513
20097292623
201013781809
201110820857
2012192901,277
201314792 (2)1,242
2014129031,178
20151911201,279
20161111611,529
201795702,081
2018611822,188
201944032,405
2020912502,443
202146112,492
2022812202,155
2023616701,807
202464321,913
202539012,073
202642050—

What is it indicated for?

The Bipore PTA catheters are indicated for percutaneous transluminal angioplasty of the iliac, femoral, and renal arteries, and for the treatment of obstructive lesions of autologous or synthetic arteriovenous dialysis fistulae.

The Bipore Inc. PTA Balloon Dilatation Catheter is also indicated for post-deployed stent expansion. Use of the Bipore Dilatation Catheter for post-deployment stent expansion was demonstrated on the bench with the Cordis Palmaz™ stent*.

All stents must be implanted and deployed according to the stent manufacturer's indications, contraindications, and instructions for use.

Testing included: Rated Burst Pressure within the Stent

Balloon Fatigue within the Stent

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K973563: Bipore Balloon Dilatation Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K973563

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026